$212.6 Million Worldwide Ultraviolet Germicidal Irradiation Industry to 2027 – Impact of COVID-19 on…

first_img Twitter Pinterest By Digital AIM Web Support – April 6, 2021 Facebook WhatsApp Local NewsBusiness Facebook Twittercenter_img WhatsApp DUBLIN–(BUSINESS WIRE)–Feb 24, 2021– The “Ultraviolet Germicidal Irradiation – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The publisher brings years of research experience to the 7th edition of this report. The 131-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Global Ultraviolet Germicidal Irradiation Market to Reach $401.2 Million by 2027 Amid the COVID-19 crisis, the global market for Ultraviolet Germicidal Irradiation estimated at US$212.6 Million in the year 2020, is projected to reach a revised size of US$401.2 Million by 2027, growing at a CAGR of 9.5% over the period 2020-2027. Air Disinfectant, one of the segments analyzed in the report, is projected to record 9.6% CAGR and reach US$346.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Surface Disinfectant segment is readjusted to a revised 8.9% CAGR for the next 7-year period. The U.S. Market is Estimated at $63 Million, While China is Forecast to Grow at 8.9% CAGR The Ultraviolet Germicidal Irradiation market in the U.S. is estimated at US$63 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$69.5 Million by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.8% and 7.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.7% CAGR. Competitors identified in this market include, among others:American UltravioletAtlantic Ultraviolet CorporationGeneral Electric CompanyHalma plcRoyal Philips Electronics N. V.UltraViolet Devices, Inc. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEWGlobal Competitor Market SharesUltraviolet Germicidal Irradiation Competitor Market Share Scenario Worldwide (in %): 2019 & 2025Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE III. MARKET ANALYSIS IV. COMPETITIONTotal Companies Profiled: 47 For more information about this report visit https://www.researchandmarkets.com/r/sdyutp View source version on businesswire.com:https://www.businesswire.com/news/home/20210224005735/en/ CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: CHEMICALS/PLASTICS HEALTH INFECTIOUS DISEASES MANUFACTURING OTHER HEALTH OTHER MANUFACTURING SOURCE: Research and Markets Copyright Business Wire 2021. PUB: 02/24/2021 10:52 AM/DISC: 02/24/2021 10:52 AM http://www.businesswire.com/news/home/20210224005735/en $212.6 Million Worldwide Ultraviolet Germicidal Irradiation Industry to 2027 – Impact of COVID-19 on the Market – ResearchAndMarkets.com Pinterest TAGS  Previous articleGIRLS HIGH SCHOOL SOCCER: Big second half helps Lady Panthers stay unbeatenNext articleA shot in the arm: EU vaccine program struggles to speed up Digital AIM Web Supportlast_img read more

Doctors say a quarter of allsicknote requests are bogus

first_imgDoctors receive 22 million requests for sicknotes every year, andÊbelieveÊ9million of these are suspect, according to insurer Norwich Union. Its Health of the Nation Index found that GPs think almost a quarter of the577 requests for sicknotes they each get a year are questionable, at best, andnearly a fifth are invalid. AlmostÊ3 million workers across the country admitted they would considerasking their GP for a bogus sicknote, with twice as many men than women sayingthey would cheat the system. More than a fifth of the GPs interviewed said up to 20 per cent of theirpatients were unable to work because of health reasons. However, many GPs thought the numbers of people on sick leave could bereduced if there were fewer delays in treatment, and if organisations arrangedto have their employees back to work in a different capacity. Four out of 10 of the GPs interviewed thought more than a third of theirpatients who were unable to work could actually work a few hours a day or in aslightly different role, but employers were not encouraging them to return towork. The most frequent causes for sicknote requests were back pain, followed bydepression, workplace stress, other stress-related problems and the flu The top five reasons for requesting a sicknote were: a personal crisis thatcould not be discussed with an employer, workplace too stressful, a holidayrequest refused, and “to give me a legitimate excuse to skive offwork”. Doug Wright, clinical development manager at Norwich Union Healthcare, said:”If patients were to educate themselves more about their condition, aswell as the other forms of support available, this could not only reduce thenumbers seeing GPs, but will actually benefit patients’ health in thelong-term.” Doctors say a quarter of allsicknote requests are bogusOn 1 Jun 2004 in Personnel Today Related posts:No related photos. Comments are closed. Previous Article Next Articlelast_img read more